Business

CDH17 granted FDA Orphan Drug Designation for Gastric Cancer

CDH17 granted FDA Orphan Drug Designation for Gastric Cancer

Chimeric Therapeutics LimitedDecember 7, 20253

CDH17 granted FDA Orphan Drug Designation for Gastric Cancer

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

CHM ceases enrolment in Phase 1 trial and Company update

August 18, 2026

Chimeric receives $1.62M advance on FY26 R&D tax incentive

July 29, 2026

All Chimeric Therapeutics Limited news →